Emeritus Professor

David Blair

AO FAA

David Blair
Image Description
David Blair is an experimental physicist, who has pioneered three separate areas of precision measurement science. He pioneered ‘microwave cavity electro-mechanics’ (which make ultra-sensitive displacement measurements that harness electromagnetic springs and self-cooling), the use of ‘whispering gallery modes in sapphire’ (for the creation of exceptionally low noise clocks and oscillators), and the study of ‘three mode interactions’ (that underpinned the detection of gravitational waves in 2015). Blair also led the creation of the Australian International Gravitational Research Centre in Western Australia, which contributed to the LIGO Scientific Collaboration and helped enable the detection of gravitational waves.

Expertise type

  • Astrophysics
  • Gravitational Waves
  • Instrumentation
  • Opto-mechanics
  • Physics Education
  • Physics

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Dacheng Tao

FAA

Dacheng Tao
Image Description
Dacheng Tao has made ground-breaking contributions in artificial intelligence, computer vision image processing and machine learning. More specifically, he has made fundamental research contributions to learning succinct, robust, and effective representations for data sampled from high dimensional or high order spaces, and collected from multiple tasks or sources. He has contributed insightful new ways to explain why, when and how a learning model performs well, and has developed useable algorithms for practical applications, such as face recognition, autonomous driving, web image search, and activity analysis. Tao has received many prizes for his research contributions and won international competitions for his applied algorithms.

Fields of research

46 INFORMATION AND COMPUTING SCIENCES
  • 4602 ARTIFICIAL INTELLIGENCE AND IMAGE PROCESSING
  • 4603 COMPUTER VISION AND MULTIMEDIA COMPUTATION
    • 460304 Computer Vision
    • 460306 Image Processing
  • 4605 DATA MANAGEMENT AND DATA SCIENCE
    • 460502 Data mining and knowledge discovery

For full list of research codes, please visit the ARC Website .

Expertise type

  • Artificial Intelligence
  • Computer Vision
  • Machine Learning
  • ICT
  • Data Science
  • Deep Learning
  • Image Processing
  • Video Surveillance
  • Acoustics

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Alan Andersen

FAA

Alan Andersen
Image Description
Alan Andersen is international recognised as the leading ant community ecologist in the world. He has pioneered the use of groups of functionally similar species to gain a predictive understanding of responses of ant communities to environmental stress and disturbance. Andersen has applied this to using ants as bio-indicators in land management, and is an international leader in the use of invertebrates in environmental assessment and monitoring. He has also made internationally important contributions to fire ecology, underpinning fire management for biodiversity conservation.

Fields of research

31 BIOLOGICAL SCIENCES
  • 3103 ECOLOGY
    • 310302 Community Ecology
    • 310308 Terrestrial Ecology
41 ENVIRONMENTAL SCIENCES
  • 4102 ECOLOGICAL APPLICATIONS
  • 4104 ENVIRONMENTAL SCIENCE AND MANAGEMENT
    • 410401 Conservation and biodiversity
    • 410402 Environmental assessment and monitoring
    • 410407 Wildlife and Habitat Management
410102 Ecological Impacts of Climate Change

For full list of research codes, please visit the ARC Website .

Expertise type

  • Biodiversity
  • Ant-Plant Interactions
  • Ants
  • Biogeography
  • Bioindicators
  • Community Ecology
  • Disturbance Ecology
  • Fire Ecology
  • Myrmecochory
  • Functional Groups
  • Global Ecology
  • Seed Predation
  • Tropical Savannas
  • Biology

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Joseph Trapani

AO FAA FAHMS

Joseph Trapani
Image Description
Joe Trapani is an immunologist whose research focuses on how cells of the immune system kill harmful cells - those infected with a virus or undergoing cancerous transformation. Trapani discovered several diverse toxins that mediate cell death, and determined how they function, individually and in synergy. His studies also address structure/function relationships for the pore-forming protein perforin and the signalling pathways activated by the ‘granzyme’ proteases to induce target cell apoptosis. Trapani also elucidated how defects in cell death pathways impinge on human health/disease, and how immune ‘killer cells’ can be harnessed as therapies for cancer, viral and auto-immune diseases.

Expertise type

  • Immunology
  • Apoptosis
  • Cytotoxic T Lymphocyte
  • Cancer Immunotherapy
  • Medical Sciences
  • CAR T cell
  • Granzyme
  • Immune-oncology
  • Perforin
  • Secretory Lysosome
  • Cancer Immunology
  • Natural Killer Cell
  • Cancer

Please contact fellowship@science.org.au to request any updates to the data.

Dr

Annabelle Bennett

AC FAA

Annabelle Bennett
Image Description
Annabelle Bennett is an internationally recognised leader in Intellectual Property (IP) patent law, specializing in scientific, medical and information technology issues. As a Federal Court Judge (with a PhD in Biochemistry) she delivered nearly 500 decisions concerning IP, including 281 judgments in patent matters, 78 concerning trademarks and 111 on copyright. Bennett has also made significant contributions to Australian science through her tireless service on numerous boards and advisory groups, including as: Chair of the ANSTO Board; Director of the Garvan Institute of Medical Research; Member of the Advisory Board of Questacon; and Chair of the World Intellectual Property Organisation Advisory Group of Judges. She is a former Chair of the National Health and Medical Research Council, Director of the Sydney Children’s Hospital Foundation, Pro-Chancellor of the Australian National University, President of Chief Executive Women and Chair of the EEO Committee of the New South Wales Bar Association.

Expertise type

  • mRNA Export
  • Multi-pathogen Resistance
  • Biology

Please contact fellowship@science.org.au to request any updates to the data.

Professor

Peter Høj

AC FAA FTSE

Peter Høj
Image Description
Peter Høj has made distinguished contributions to Australian society, particularly through more than two decades of leadership as Vice-Chancellor of the University of Adelaide, the University of Queensland and the University of South Australia, and as CEO of the Australian Research Council and the Australian Wine Research Institute, Høj has also been a member of numerous high-level policy committees, following his earlier career as one of Australia’s leading young biochemists.

Fields of research

31 BIOLOGICAL SCIENCES
  • 3101 BIOCHEMISTRY AND CELL BIOLOGY
    • 310199 Biochemistry and Cell Biology not elsewhere classified
  • 3106 INDUSTRIAL BIOTECHNOLOGY
    • 310601 Biocatalysis and Enzyme Technology
    • 310603 Fermentation
32 BIOMEDICAL AND CLINICAL SCIENCES
  • 3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS
    • 320506 Medical Biochemistry: Proteins and Peptides (incl. Medical Proteomics)

For full list of research codes, please visit the ARC Website .

Expertise type

  • Biological Chemistry
  • Protein Structure
  • Biochemistry
  • Protein Structure-Function Relationships
  • Analytical Chemistry
  • Chemistry

Please contact fellowship@science.org.au to request any updates to the data.

Position statement – Openness Agreement on Animal Research and Teaching in Australia

The Academy's position on the use of animals in scientific research and teaching.

Image Description

Scientists and scientific organisations should be transparent and open about the use of animals in research and teaching and must maintain the highest ethical standards for this work.

The Australian Academy of Science supports the Openness Agreement on Animal Research and Teaching in Australia and was an inaugural supporter at the launch of the Openness Agreement on 10 August 2023.

Research roadmap for blood cancer

A 10-year plan to accelerate blood cancer research in Australia, with a national quest to achieve zero preventable deaths by 2035.

Image Description

The Leukaemia Foundation on behalf of the Blood Cancer Taskforce partnered with the Australian Academy of Science to develop a 10-year research roadmap to accelerate blood cancer research in Australia. 

The Academy, in collaboration with the Australian Academy of Health and Medical Sciences (AAHMS), developed the roadmap to identify priority areas for research activity and investment, and barriers and opportunities for research advancement and translation into clinical care.

Executive summary

Blood cancers are one of the most common cancers globally and are expected to become the most prevalent and deadly form of cancer in Australia by 2035.

Incidence has risen by 47% over the past decade, far outpacing population growth, and is expected to double in the next decade.

The cause of this increase is unknown, but understanding it is critical to developing new treatment and management options. Blood cancers are typically non-hereditary, non-screenable, and spontaneous cancers, with more than 100 subtypes, making detection and treatment challenging.

Past research has delivered dramatic gains in survival for some specific blood cancers. For those difficult-to-treat blood cancers with high mortality rates, new research is the only way to improve outcomes.

Immediate action is needed

Right now, we are losing the race. To reverse or slow the rise of blood cancer incidence, and to minimise deaths and impacts, Australia must increase its investment in research – both fundamental and applied – and the workforce that drives it.

Current funding is not sufficient to meet the existing challenge of high-mortality blood cancers, nor to avert the rising incidence.

This is a once-in-a-generation opportunity to build a coordinated and strategic approach and to pioneer new treatments for blood cancer, building on the foundation of our existing research strengths and clinical trial capability.

The quest: Zero preventable deaths by 2035

We propose a national quest, supported by government, industry and philanthropic stakeholders, to fast-track research efforts, leverage existing infrastructure and strengths, and build new opportunities and capacity. The quest will address the overarching issues applicable to all healthcare and cancer research and is a shared responsibility of all health researchers to emphasise areas where we can make the greatest differences.

This national quest has the following three priorities.

  • Investment in research: Increasing funding for blood cancer research – including fundamental research – with dedicated funding streams to tackle areas of particular need, including difficult-to-target and high-mortality cancers.
  • Translation of research into practice: Improving national coordination of research, incentivising multidisciplinary teamwork, enabling strategic international collaboration and partnerships, and supporting large-scale clinical trials.
  • Build the research workforce: Bridging the gap between research and clinical care by empowering researchers and clinician–researchers with the skills, resources, and support they need to conduct research, advance health and medical knowledge, and improve patient care and outcomes.

Three blood cancer missions

To support the quest for zero preventable deaths by 2035 and deliver this Research Roadmap, three missions have been identified that address areas of high unmet need. Each mission offers a new focus for blood cancer research. The Australian Government must lead the investment of $125 million into blood cancer research, spread across the three national missions.

  1. Blood cancers with poor outcomes: We need to explore better options to manage cancers such as acute myeloid leukaemia (AML), poor prognosis multiple myeloma, recurrent aggressive lymphomas, and currently intractable rare blood cancers.
  2. Causality and potential for prevention and early detection: This mission should focus on including early detection in populations and the small subset of individuals known to be of high risk of developing a blood cancer – from environmental influences, prior cancer therapy and heritable factors.
  3. Personalised medicine: The third mission should focus on integrating advanced genomics, and targeted and cellular therapies in models of care, aiming to change the natural history of blood cancers.

Expert steering group

Issues paper: Incentivising business investment in R&D

The Australian Academy of Science is calling for an urgent national conversation on research and development investment in Australia.

Image Description

Australia’s persistent underinvestment in R&D threatens our productivity, limits wage growth, threatens our standard of living, and weakens our ability to respond to global volatility. These threats have consequences for every member of society.

This issues paper makes the case for investment in the underpinnings of an Australian future that is flourishing, fair and secure.

The paper outlines the Academy’s proposal to incentivise business R&D investment by applying either a 0.25% or 0.5% R&D levy to businesses with annual revenue of $100 million or more that can be discounted if businesses invest in R&D.

The fact sheet (page 10) provides independent economic analysis of the measure and outlines its impact.

*Correction: The issues paper and fact sheet document was amended on 31 July 2025 to reflect that increases to the RDTI expenditure threshold caps were from $100 million to $150 million. A previous version stated this increase was to $200 million.

International scientific collaborations in a contested world: Summary of the National Symposium, November 2023

Exploring the role of science in an uncertain geopolitical landscape.

Image Description

In November 2023, the Australian Academy of Science facilitated a national dialogue about how national security concerns can be addressed while enabling the benefits that open scientific collaboration offers Australia and the world.

This report summarises the issues examined by the keynote speakers and panellists across the symposium. 

The key symposium messages were that:

  • continued international scientific collaboration is in Australia’s national interest
  • responses to national security threats need to be evidence-informed and proportional
  • science is a diplomatic asset.

Find out more about the symposium